Physician profile
James Siegert
NPI 1245556224
$36,589.48
in general payments reported to CMS, 2019-2025
32 companies · $2,448 in 2025
The $2,448 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $1,129 · 2021: $1,370 · 2022: $4,228 · 2023: $5,810 · 2024: $9,704 · 2025: $2,448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $3,461 · Travel and Lodging: $2,227 · Consulting Fee: $1,750 · Honoraria: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,388.00 |
| Food and Beverage | $3,461.27 |
| Travel and Lodging | $2,226.54 |
| Consulting Fee | $1,750.00 |
| Honoraria | $136.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $20,955.57 | 2019-2025 | General - Kidney Stone Disease, Lithovue, Spaceoar Vue System - 10ml |
| Astellas Pharma US INC | $11,610.24 | 2019-2025 | Xtandi |
| Abbvie INC. | $797.29 | 2022-2025 | Botox |
| Stryker Corporation | $750.00 | 2024 | |
| Axonics, INC. | $466.05 | 2021-2023 | Axonics |
| Medtronic, INC. | $396.00 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $233.07 | 2019-2024 | Bard Urinary Drainage Bag |
| Intuitive Surgical, INC. | $190.00 | 2019-2023 | Da Vinci Sp |
| Allergan, INC. | $179.28 | 2020-2021 | |
| Astrazeneca Pharmaceuticals Lp | $135.44 | 2023-2025 | Lynparza |
| Valencia Technologies Corporation | $133.08 | 2025 | Ecoin Device Kit |
| Comsort, INC | $100.00 | 2019 | |
| Janssen Biotech, INC. | $76.99 | 2019-2021 | |
| Becton, Dickinson and Company | $70.56 | 2024-2025 | Bard Urinary Drainage Bag, Bard X-Force Balloon Dilation Catheter |
| Progenics Pharmaceuticals, INC. | $53.15 | 2021-2023 | Pylarify |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $52.73 | 2019-2021 | |
| Olympus America INC. | $47.32 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $34.06 | 2021-2024 | Lynparza |
| Dendreon Pharmaceuticals LLC | $33.42 | 2024 | Provenge |
| Agiliti Surgical, INC. | $32.93 | 2023 | Sonablate |
| Telix Pharmaceuticals | $29.81 | 2024 | Illuccix |
| Laborie Medical Technologies Corp. | $29.05 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Sumitomo Pharma America, INC. | $24.72 | 2024 | Orgovyx |
| Myovant Sciences INC. | $24.02 | 2021 | |
| Myriad Genetic Laboratories, INC. | $23.08 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $19.12 | 2021 | |
| Pfizer INC. | $18.85 | 2019 | |
| Biolase, INC. | $18.68 | 2019 | |
| Endo Pharmaceuticals INC. | $17.35 | 2021 | |
| Antares Pharma, INC. | $17.20 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.24 | 2023 | |
| Ambu INC. | $6.18 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Siegert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.